HER-2 codon 655 polymorphism in cervical carcinogenesis

International Journal of Gynecological Cancer

Volumn 16, Issue 1, 2006, Pages 325-328

  Ueda, M ^a   Hung, Y C ^b   Terai, Y ^a   Saito, J ^c   Nunobiki, O ^c   Noda, S ^c   Ueki, M ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c Osaka Cancer Prev Detection Ctr   (Japan)

Author keywords

Cervical carcinogenesis; HER 2; Polymorphism; SIL

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR 2; ISOLEUCINE; VALINE;

ARTICLE; CANCER PATIENT; CARCINOGENESIS; CODON; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CYTOLOGY; WART VIRUS;

BASE SEQUENCE; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CODON; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, ERBB-2; GENOTYPE; HUMANS; INCIDENCE; JAPAN; MASS SCREENING; MOLECULAR SEQUENCE DATA; NEOPLASM STAGING; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; RISK ASSESSMENT; SAMPLING STUDIES; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 33645364424     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00349.x     Document Type: Article

References (32)

1. Warwick A Sarhanis P Redman C et al Theta class glutathione S-transferase GSTT1 genotypes and susceptibility to cervical neoplasia: interactions with GSTM1, CYP2D6 and smoking Carcinogenesis 1994 15 2841 5
2. Chen C Madeleine MM Weiss NS Daling JR Glutathione S-transferase M1 genotypes and the risk of squamous carcinoma of the cervix: a population-based case-control study Am J Epidemiol 1999 150 568 72
3. Goodman MT McDuffie K Hernandez B et al CYP1A1, GSTM1, and GSTT1 polymorphisms and the risk of cervical squamous intraepithelial lesions in a multiethnic population Gynecol Oncol 2001 81 263 9
4. Storey A Thomas M Kalita A et al Role of a p53 polymorphism in the development of human papillomavirus-associated cancer Nature 1998 393 229 34
5. Rosenthal AN Ryan A Al-Jehani RM Storey A Harwood CA Jacobs IJ p53 codon 72 polymorphism and the risk of cervical cancer in UK Lancet 1998 352 871 2
6. Lanham S Campbell I Watt P Gornall R p53 polymorphism and risk of cervical cancer Lancet 1998 352 1631
7. Hayes VM Hofstra RMW Buys CHCM Hollema H van der Zee AGJ Homozygous arginine-72 in wild type p53 and risk of cervical cancer Lancet 1998 352 1756
8. Semba K Kamata N Toyoshima K Yamamoto T A v-erbB-related protooncogene, c-erbB-2, is distinct from the c-erbB-1/epidermal growth factor-receptor gene and is amplified in a human salivary gland adenocarcinoma Proc Natl Acad Sci U S A 1985 82 6497 501
9. Yamamoto T Ikawa S Akiyama T et al Similarity of protein encoded by the human c-erb-B-2 gene to epidermal growth factor receptor Nature 1986 319 230 4
10. Di Fiore PP Pierce JH Kraus MH Segatto O King CR Aaronson SA erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells Science 1987 237 178 82
11. Dowsett M Cooke T Ellis I et al Assessment of HER2 status in breast cancer: why, when and how? Eur J Cancer 2000 36 170 6
12. Hengstler JG Lange J Kett A et al Contribution of c-erbB-2 and topoisomerase IIalpha to chemoresistance in ovarian cancer Cancer Res 1999 59 3206 14
13. Nakajima M Sawada H Yamada Y et al The prognostic significance of amplification and overexpression of c-met and c-erbB-2 in human gastric carcinomas Cancer 1999 85 1894 902
14. Morote J de Torres I Caceres C Vallejo C Schwartz S Jr. Reventos J Prognostic value of immunohistochemical expression of the c-erbB-2 oncoprotein in metastasic prostate cancer Int J Cancer 1999 84 421 5
15. Vollmer RT Humphrey PA Swanson PE Wick MR Hudson ML Invasion of the bladder by transitional cell carcinoma: its relation to histologic grade and expression of p53, MIB-1, c-erbB-2, epidermal growth factor receptor, and bcl-2 Cancer 1998 82 715 23
16. Hung MC Matin A Zhang Y et al HER-2/neu-targeting gene therapy - a review Gene 1995 159 65 71
17. Kao MC Liu GY Chuang TC Lin YS Wuu JA Law SL The N-terminal 178-amino-acid domain only of the SV40 large T antigen acts as a transforming suppressor of the HER-2/neu oncogene Oncogene 1998 16 547 54
18. Bar JK Harlozinska A Sedlaczek P Kasiak J Markowska J Relations between the expression of p53, c-erbB-2, Ki-67 and HPV infection in cervical carcinomas and cervical dysplasias Anticancer Res 2001 21 1001 6
19. Kohlberger P Edwards L Hacker NF Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome Gynecol Oncol 2003 90 443 5
20. Bellone S Palmieri M Gokden M et al Selection of HER-2/neu-positive tumor cells in early stage cervical cancer: implications for Herceptin-mediated therapy Gynecol Oncol 2003 91 231 40
21. Niibe Y Nakano T Ohno T Suzuki Y Oka K Tsujii H Prognostic significance of c-erbB-2/HER2 expression in advanced uterine cervical carcinoma with para-aortic lymph node metastasis treated with radiation therapy Int J Gynecol Cancer 2003 13 849 55
22. Papewalis J Nikitin AYu Rajewsky MF G to A polymorphism at amino acid codon 655 of the human erbB-2/HER2 gene Nucleic Acids Res 1991 19 5452
23. Xie D Shu XO Deng Z et al Population-based, case-control study of HER2 genetic polymorphism and breast cancer risk J Natl Cancer Inst 2000 92 412 7
24. Baxter SW Campbell IG Re: population-based, case-control study of HER2 genetic polymorphism and breast cancer risk J Natl Cancer Inst 2001 93 557 9
25. Wang L Habuchi T Takahashi T et al No association between HER-2 gene polymorphism at codon 655 and a risk of bladder cancer Int J Cancer 2002 97 787 90
26. Ueda M Gemmill RM West J et al Mutations of the β- and γ-catenin genes are uncommon in human lung, breast, kidney, cervical and ovarian carcinomas Br J Cancer 2001 85 64 8
27. Nagano H Yoshikawa H Kawana T et al Association of multiple human papillomavirus types with vulvar neoplasias J Obstet Gynaecol Res 1996 22 1 8
28. Yoshikawa H Kawana T Kitagawa K Mizuno M Yoshikura H Iwamoto A Detection and typing of multiple genital human papillomaviruses by DNA amplification with consensus primers Jpn J Cancer Res 1991 82 524 31
29. Bargmann CI Hung MC Weinberg RA Multiple independent activations of the neu oncogene by a point mutation altering the transmembrane domain of p185 Cell 1986 45 649 57
30. Siegel PM Dankort DL Hardy WR Muller WJ Novel activating mutations in the neu proto-oncogene involved in induction of mammary tumors Mol Cell Biol 1994 14 7068 77
31. Ameyaw MM Tayeb M Thornton N et al Ethnic variation in the HER-2 codon 655 genetic polymorphism previously associated with breast cancer J Hum Genet 2002 47 172 5
32. Kuraoka K Matsumura S Hamai Y et al A single nucleotide polymorphism in the transmembrane domain coding region of HER-2 is associated with development and malignant phenotype of gastric cancer Int J Cancer 2003 107 593 6